Parallax Volatility Advisers
EVFM

Parallax Volatility Advisers’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Parallax Volatility Advisers’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,333
Closed -$70K – 3398
2021
Q4 		$70K Sell
12,333
-2,834
-19% -$24.1K ﹤0.01% 1798
2021
Q3 		$168K Buy
+15,167
New +$191K ﹤0.01% 1724

Other funds holding EVFM

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallax Volatility Advisers's EVFM Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2019, closing a stake of 10 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in EVFM in Q2 2015 and held it in 16 quarters. The position peaked at $5K in Q2 2015. 42 funds tracked by Wall St. Rank hold EVFM as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 10 Evofem Biosciences, Inc. Common Stock shares in Q3 2019, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 16 quarters.
  • Parallax Volatility Advisers's Evofem Biosciences, Inc. Common Stock position peaked at $5K in Q2 2015.
  • 42 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.